US/Israeli Regulatory Harmonization Moves

29 September 1996

The US Food and Drug Administration is to conduct a pilot project involving the extension of the Israeli Ministry of Health's authority to approve products in a number of fields, so that they are recognized by the FDA. This will involve wider cooperation between the MoH and the FDA in medical equipment, cosmetics and food products.

This was decided at a meeting in Washington of the joint USA-Israel Science & Technology Commission attended by US Vice President Al Gore and Israel's Minister of Industry, Trade and Commerce, Nathan Sharansky. The Commission includes representatives from the Israeli and US ministries of health, finance and industry from both Israel and the USA.

One project involves the evaluation of an operation model, under which two Israeli and two US firms will conduct trials on medical equipment. Tests will be done in both countries, with close cooperation, and with approval receiving FDA recognition at the same time. The project's success will allow an evaluatory framework of medical equipment to be set up in Israel which will be recognized by the FDA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight